DK169583B1 - Monoklont antistof, fremgangsmåde til dets fremstilling, hybridomcellelinie, der producerer antistoffet, fremgangsmåde til kvantitativ immunologisk bestemmelse af prokollagen-peptid (type III) med antistoffet, samt diagnostisk præparat indeholdende det monoklonale antistof - Google Patents

Monoklont antistof, fremgangsmåde til dets fremstilling, hybridomcellelinie, der producerer antistoffet, fremgangsmåde til kvantitativ immunologisk bestemmelse af prokollagen-peptid (type III) med antistoffet, samt diagnostisk præparat indeholdende det monoklonale antistof Download PDF

Info

Publication number
DK169583B1
DK169583B1 DK232888A DK232888A DK169583B1 DK 169583 B1 DK169583 B1 DK 169583B1 DK 232888 A DK232888 A DK 232888A DK 232888 A DK232888 A DK 232888A DK 169583 B1 DK169583 B1 DK 169583B1
Authority
DK
Denmark
Prior art keywords
type iii
antibody
monoclonal antibody
peptide
procollagen peptide
Prior art date
Application number
DK232888A
Other languages
Danish (da)
English (en)
Other versions
DK232888D0 (da
DK232888A (da
Inventor
Dietrich Brocks
Juergen Puenter
Helmut Strecker
Rupert Timpl
Original Assignee
Hoechst Ag
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag, Max Planck Gesellschaft filed Critical Hoechst Ag
Publication of DK232888D0 publication Critical patent/DK232888D0/da
Publication of DK232888A publication Critical patent/DK232888A/da
Application granted granted Critical
Publication of DK169583B1 publication Critical patent/DK169583B1/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Pressure Welding/Diffusion-Bonding (AREA)
DK232888A 1987-05-02 1988-04-28 Monoklont antistof, fremgangsmåde til dets fremstilling, hybridomcellelinie, der producerer antistoffet, fremgangsmåde til kvantitativ immunologisk bestemmelse af prokollagen-peptid (type III) med antistoffet, samt diagnostisk præparat indeholdende det monoklonale antistof DK169583B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3714633 1987-05-02
DE3714633 1987-05-02

Publications (3)

Publication Number Publication Date
DK232888D0 DK232888D0 (da) 1988-04-28
DK232888A DK232888A (da) 1988-11-03
DK169583B1 true DK169583B1 (da) 1994-12-12

Family

ID=6326685

Family Applications (1)

Application Number Title Priority Date Filing Date
DK232888A DK169583B1 (da) 1987-05-02 1988-04-28 Monoklont antistof, fremgangsmåde til dets fremstilling, hybridomcellelinie, der producerer antistoffet, fremgangsmåde til kvantitativ immunologisk bestemmelse af prokollagen-peptid (type III) med antistoffet, samt diagnostisk præparat indeholdende det monoklonale antistof

Country Status (10)

Country Link
EP (1) EP0289930B1 (fr)
JP (1) JPH07110879B2 (fr)
AT (1) ATE89862T1 (fr)
DE (1) DE3881275D1 (fr)
DK (1) DK169583B1 (fr)
ES (1) ES2056850T3 (fr)
FI (1) FI96433C (fr)
IE (1) IE63371B1 (fr)
NO (1) NO173104C (fr)
PT (1) PT87376B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679583A (en) * 1987-05-02 1997-10-21 Hoechst Aktiengesellschaft Monoclonal antibodies for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids
GB2208865B (en) * 1987-08-19 1991-12-11 Farmos Group Ltd Purified propeptide of procollagen type iii, antibody to the propeptide and assay method using the antibody.
US6010862A (en) * 1987-11-06 2000-01-04 Washington Research Foundation Methods of detecting collagen type III degradation in vivo
US7541149B1 (en) 1998-05-28 2009-06-02 Siemens Healthcare Diagnostics, Inc. Monoclonal antibody and assay for detecting PIIINP
US6602980B1 (en) 1998-06-19 2003-08-05 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
US6916903B2 (en) 1998-06-19 2005-07-12 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3209149A1 (de) * 1982-03-13 1983-10-06 Hoechst Ag Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum

Also Published As

Publication number Publication date
FI882019L (fi) 1988-11-03
JPH07110879B2 (ja) 1995-11-29
DK232888D0 (da) 1988-04-28
NO881905D0 (no) 1988-04-29
IE63371B1 (en) 1995-04-19
ES2056850T3 (es) 1994-10-16
FI96433B (fi) 1996-03-15
EP0289930A3 (fr) 1991-06-12
FI882019A0 (fi) 1988-04-29
EP0289930A2 (fr) 1988-11-09
JPS63296695A (ja) 1988-12-02
EP0289930B1 (fr) 1993-05-26
NO881905L (no) 1988-11-03
PT87376B (pt) 1992-08-31
DK232888A (da) 1988-11-03
ATE89862T1 (de) 1993-06-15
NO173104B (no) 1993-07-19
DE3881275D1 (de) 1993-07-01
IE881290L (en) 1988-11-02
FI96433C (fi) 1996-06-25
PT87376A (pt) 1989-05-31
NO173104C (no) 1993-10-27

Similar Documents

Publication Publication Date Title
Curtiss et al. A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins.
Young et al. Conservation of the low density lipoprotein receptor-binding domain of apoprotein B. Demonstration by a new monoclonal antibody, MB47.
DK169571B1 (da) Monoklont antistof, fremgangsmåde til dets fremstilling, hybridomcellelinie, der producerer antistoffet, fremgangsmåder til kvantitativ immunologisk bestemmelse af prokollagen-peptid (type III) med antistoffet, samt diagnostisk præparat indeholdende det monoklonale antistof
EP0454782B1 (fr) Haptoglobine apparentee au cancer (hpr)
DK168872B1 (da) Fremgangsmåde til fremstilling af antistoffer til immunologisk bestemmelse af aminoterminalt prokollagen peptid (type III) og/eller prokollagen (type III), antistoffer fremstillet ved fremgangsmåden, anvendelsen af antistofferne til immunologisk bestemmelse af aminoterminalt prokollagen peptid (type III) og/eller prokollagen (type III) og udgangsprodukt til brug ved fremgangsmåden
AU715797B2 (en) Methods for determining the presence of brain protein S-100
JP3018110B2 (ja) モノクローナル抗体
US5679583A (en) Monoclonal antibodies for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids
CA2155793C (fr) Anticorps monoclonaux pour l'analyse immunologique selective de formes intactes de laminine de masse moleculaire elevee dans des fluides corporels
NO173104B (no) Monoklonalt antistoff til selektiv immunologisk bestemmelse av intakt prokollagenpeptid (type iii) og prokollagen (type iii), en hybridoma cellelinje som produserer dette antistoff samt et preparat inneholdende antistoffet
CA1337926C (fr) Methode de dosage de l'insuline humaine
JP3894381B2 (ja) 抗Ｇｌｕ▲１７▼−オステオカルシン抗体
Banga et al. Analysis of antigenic determinants of retinal S-antigen with monoclonal antibodies.
US5514599A (en) Antibodies against highly conserved amino acid sequences of insulin a process for the preparation of these antibodies and the use thereof in immunoassays
Gibson et al. Discrimination between β‐endorphin and β‐lipotrophin in human plasma using two‐site immunoradiometric assays
AU600261B2 (en) Reagent for and procedure in the determination of C3a by immunochemical assay
JP3107248B2 (ja) 抗体および免疫化学的測定法
Zenke et al. Characterization of a major human antibody clonotype (1A) by monoclonal antibodies to combining siteassociated idiotopes
JPH0746105B2 (ja) インタ−フエロン−γの免疫化学的測定法および測定用試薬
JPWO1993025701A1 (ja) ヒト肺サーフアクタントアポ蛋白ｄに対するモノクローナル抗体およびその用途
JPWO1992006377A1 (ja) オステオカルシンのプロペプチド、プロオステオカルシンを免疫学的に測定するための方法及びキツト
Mikami et al. Studies on immunological assay of vitamin‐K dependent factors. III. A DOUBLE MONOCLONAL IMMUNORADIOMETRIC ASSAY FOR FACTOR IX ANTIGEN
JPH06100599A (ja) 扁平上皮癌関連抗原及びその免疫学的利用方法
JP2007045834A (ja) 抗Ｇｌｕ１７−オステオカルシン抗体
DK161098B (da) Antistoffer mod modificeret beta2-mikroglobulin, fremgangsmaader til detektering af modificeret beta2-mikroglobulin samt farmaceutiske praeparater indeholdende saadanne antistoffer

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK